Form 4 for CRL Charles River Laboratories
Accepted 2024-11-08 00:00:00 ET · period of report 2024-11-07 · accession 0001127602-24-026871 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-11-08 | 2024-11-07 | CRL | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | -470 | 23.3K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-07 | G | D | 470 | $0.00 | 23,337 | I By Trust | — | — | (F1) Reflects the exempt transfer pursuant to Rule 16a-13 of 965 shares held by the reporting person to William D. Barbo Revocable Trust. |